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Actin and its associated proteins participate in several intracellular trafficking mechanisms. This review assesses recent work that shows
how actin participates in the terminal trafficking event of membrane bilayer fusion. A recent flurry of reports defines a role for Rho proteins
in membrane fusion and also demonstrates that this role is distinct from any vesicle transport mechanism. Rho proteins are well known to
govern actin remodeling, which implicates this process as a condition of membrane fusion. A small but significant body of work examines
actin-regulated events of intracellular membrane fusion, exocytosis and endocytosis. In general, actin has been shown to act as a negative
regulator of exocytosis. Cortical actin filaments act as a barrier that requires transient removal to allow vesicles to undergo docking at the
plasma membrane. However, once docked, F-actin synthesis may act as a positive regulator to give the final stimulus to drive membrane
fusion. F-actin synthesis is clearly needed for endocytosis and intracellular membrane fusion events. What may seem like dissimilar results
are perhaps snapshots of a single mechanism of membranous actin remodeling (i.e. dynamic disassembly and reassembly) that is universally
needed for all membrane fusion events.D 2003 Elsevier B.V. All rights reserved.Keywords: Actin; Actin ligand; Rho; Membrane fusion; Exocytosis1. Introduction
It has become increasingly apparent in recent years that
the actin cytoskeleton and its associated proteins play a vital
role in intracellular vesicle trafficking. Vesicle budding and
movement is driven on actin cables through an association
with actin-based motor proteins or by rapid actin polymer-
ization to produce vectoral force [1–3]. These transport
mechanisms and the proteins involved are the subjects of
several good reviews [4–6]. This review emphasizes a
secondary role for actin that is beginning to emerge; the
specific need for actin remodeling to drive the last step of
membrane fusion—lipid bilayer mixing.
Early ultrastructural studies of actively secreting cells,
such as pancreatic or neuronal cells, revealed an extensive
actin networks and a dense subplasmalemmal actin cortex
[7,8]. Though primarily needed to give cells their shape, one
could also predict that this zone poses an obstacle that
impedes exocytosis and endocytosis at the plasma mem-
brane. Therefore, vesicular trafficking would require an0167-4889/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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ment through cortical actin or actin-based motor proteins to
drive budding and fusion. Active cytoskeletal rearrange-
ments have been shown to accompany many vesicle trans-
port and fusion events in a variety of cell systems [1,9,10].
The data from many of these experiments have been
interpreted in support of the actin-physical-barrier model
and that transient depolymerization of F-actin is needed so
vesicles can gain access to their appropriate docking and
fusion sites.
However, actin has been shown to play both inhibitory
and facilatory roles in membrane fusion and not all studies
support the simplified actin-barrier model [11–14]. Mem-
brane lipid bilayers do not undergo fusion spontaneously.
There is a large electrostatic force between two lipid bilayers
that opposes their juxtapositioning [15]. A role for actin
remodeling that includes a rearrangement to form structures
that spatially restrict fusogenic proteins to active fusion sites
and/or the ability to apply a constrictive force would be a
compelling mechanism of overcoming such an opposing
force.
This review will highlight some of the recent advances
documented for the requirement of actin remodeling during
exocytosis and endocytosis. New results from in vitro
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contributions, may prompt us to reexamine our interpreta-
tion of earlier in vivo results.2. How is actin remodeled?
2.1. Signaling pathways from Rho for actin remodeling
The ability of Rho proteins to control actin dynamics has
been well characterized and, in yeast, is important for
directing polarized secretion to the bud site [16,17]. A flurry
of recent reports has documented the requirement for
Rho1p, Rho3p and Cdc42p in yeast membrane fusion
reactions [18–25]. Importantly, roles have been attributed
to mechanisms outside of cytoskeletal vesicular transport.
Indeed, Adamo et al. [24] report the isolation of a specific
yeast mutant of Cdc42p defective only in the late stages of
exocytosis with no apparent defects in cytoskeletal organi-
zation, polarized vesicle delivery or localization of protein
complexes needed at the site of exocytosis. We have also
recently reported that Rho1p and Cdc42p are enriched on
the vacuole membrane and both are required for in vitro
homotypic vacuole fusion in the absence of cytoskeleton,
thus eliminating possible effect of cytoskeletal transport
[22,23]. Rho proteins have also been shown to control
exocytosis in rat peritoneal mast cells independently of
effecting cytoskeleton [26,27] and to control neuronal
synaptic transmission [28,29]. Rho proteins also modulateFig. 1. Downstream targets of RhoA (Rho1 in yeast) and Cdc42, and the reaction p
humans, mouse and rat; Sc, Saccharomyces cerevisiae homologues; Sp, Schizosacccellular processes other than cytoskeletal rearrangements
and these may in turn affect membrane fusion indirectly;
however, this is beyond the scope of this review.
Given the recent evidence that Rho proteins are needed
for membrane fusion outside of affecting transport, the next
logical question is what downstream effector complexes
could mediate Rho effects on actin and membrane fusion?
Multiple downstream effector complexes directly link Rho
proteins to actin cytoskeleton rearrangement capabilities,
which are summarized in Fig. 1 (for reviews see Refs.
[30–32]).
2.2. Membrane-bound actin regulation pathways
Further limitations can be placed on the set of effectors in
Fig. 1 by sorting out those that have been reported to affect
trafficking in general or, more specifically, membrane fu-
sion. The most obvious candidate in this respect is PI 5-
kinase which generates the lipid signaling molecule, phos-
phatidylinositol 4,5-bisphosphate (PI(4,5)P2). PI(4,5)P2 is
an important molecule for membrane assembly of tethering
complexes in trafficking and is deemed to spatially locate
active zones for vesicle targeting, docking and fusion (for
review see Ref. [33]). It is also known to regulate actin
dynamics; however, these two roles have been largely
presumed to be mutually exclusive of one another.
PI(4,5)P2 can induce actin remodeling via activation of
WASp [3] and WASp enhances the actin nucleating activity
of the Arp2/3 complex severalfold [34]. Isolated yeastathways that lead to actin rearrangements.M, mammalian proteins including
haromyces pombe homologues; Dm, Drosophila melanogaster homologues.
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homotypic membrane fusion reactions, which are also
sensitive to ligands of PI(4,5)P2 [35] and the yeast WASp
protein Las17 [14]. Rigorous localization studies of the actin
remodeling pathway from PAK, WASp and Arp2/3 have not
been done though these proteins are all enriched on isolated
vacuoles [14]. PI(4,5)P2 also stimulates the actin nucleating
activity of a second family of actin binding proteins called
ERMs for ezrin/radixin/moesin [36]. PI 5-kinase and ERM
proteins have recently been shown to be involved in actin
polymerization on isolated phagosomes [37,38], which in
turn may facilitate their fusion [13]. Protein kinase C (PKC),
a downstream effector of RhoA (Rho1 in yeast), is found
primarily membrane-bound, and can signal events for both
actin polymerization and depolymerization through activa-
tion of distinct pathways [39]. It has recently been shown
that PKC participates in yeast ER membrane fusion [40]. It
would be a compelling evidence that actin rearrangements
directly promote membrane fusion if these signaling cas-
cades showed either permanent membrane localization or
membrane recruitment to active fusion zones.
2.3. Membrane association of actin and actin dynamics
The previous section discusses a body of work that
supports several roles for Rho proteins and their effectors
in membrane fusion. However, these studies have not
always provided a direct link to the regulation actin remod-
eling on membranes in support of fusion. If actin remodel-
ing is believed to be involved in the membrane fusion
process, then the proteins that catalyze this mechanism must
be localized or actively recruited to fusion sites and perhaps
even interact with known fusion molecules. All Rho pro-
teins bear a carboxyl lipid modification (isoprenylation) and
are therefore normally found on membranes. Localization
studies show their enrichment at the plasma membrane and
specifically at sites of active growth such as neuronal
growth cones or the incipient bud site in yeast [17,41].
Minor portions have also been localized to other intracellu-
lar membranes such as the Golgi apparatus, secretory
vesicles and vacuoles/lysosomes. At these sites they may
act to locally recruit (from the cytosol or the surrounding
membrane) and activate an actin remodeling mechanism. A
prime example of this is on the Golgi membrane where Arf
has been shown to recruit a complex of Cdc42 and coatomer
[42]. Cdc42 then stimulates actin polymerization via acti-
vation of WASp and Arp2/3. At the plasma membrane a
similar mechanism exists. Intersectin, which is recruited into
clatherin-coated pits, can inhibit Cdc42 GAP activity, and
neuronal intersectin-1 contains a Dbl domain that acts as a
nucleotide exchange factor for Cdc42p [43,44]. This pro-
vides a mechanism for the local activation of Cdc42 at
plasma membrane endocytosis sites, where it can also signal
for actin polymerization via WASp and Arp2/3 recruitment.
Direct localization of Rho effectors, actin binding pro-
teins and actin itself on membrane vesicles has also beenshown. The Cdc42 effector, IQGAP, is enriched on Golgi
membranes in several cell types [45]. PKC translocates to a
variety of subcellular organelles upon activation (via its
potent activator phorbol myristate acetate, PMA) and these
organelles then become active sites of actin polymerizing
activity [46,47]. WASp and its associated protein WIP
(Las17 and Vrp1 in yeast) show plasma membrane and
Golgi association and are also recruited to lysosomes,
endosomes and the vacuole by a mechanism that may
involve PKC [14,42,46–48].
Actin co-purifies with many organelles, which are capa-
ble of actin nucleating activity both in vivo and in vitro
when reconstituted with cytosol. Several examples of this
exist in many cell types. Activation of PKC in Xenopus
oocytes results in the recruitment of WASp to endosomes
and lysosomes and the concomitant formation of F-actin
[46]. A selected pool of zymogen granules becomes coated
with actin filaments prior to secretion in pancreatic acinar
cells [49]. In this study, actin coating corresponds with the
release of rab3D, a protein required for vesicle docking, and
therefore it is likely that actin coat formation is necessary for
a post-docking fusion mechanism. In addition, F-actin-
disrupting drugs (latrunculin B and cytochalasin D) had
no effect, while the F-actin stabilizing drug, jasplakinolide,
inhibited exocytosis.
A powerful example of membrane-associated actin
remodeling comes from studies of purified latex bead
phagosomal membranes. The PI 4- and PI 5-lipid kinases,
are obligatory membrane-bound activators that produce the
lipid signaling molecule PI(4,5)P2. These kinases have
recently been localized to purified phagosomal membranes
[38]. PI(4,5)P2 activates ERM proteins, which normally
reside as homo-oligomers in an inactive form in the cytosol.
Once activated, oligomers dissociate, which facilitates their
membrane association and actin nucleating activity. ERM
activity has been shown on these isolated phagosomes (and
at the plasma membrane) where it is thought to facilitate
organelle aggregation and membrane fusion [37,50]. Phag-
osomes can nucleate the formation of F-actin in the presence
of pure actin or cytosolic extracts [13]. Inhibition of PI 4-
and PI 5-kinase activity leads to a reduction in actin
nucleating activity, whereas incorporation of PI(4,5)P2 into
phagosomes stimulates actin nucleating activity [38]. Endo-
cytic vesicles also assemble large amounts of F-actin via a
pathway that is activated by PI 5-kinase [3,51]. Vesicles
appear to grow actin-comet tails, which are thought to
propel the organelle through the cytosol. An extension of
such a mechanism to membrane fusion can be drawn as
organelles are driven to docking sites and propelled to fuse.
Actin nucleating activity is ultimately controlled by Rho
proteins, which also interact with vesicle trafficking ma-
chinery. With the recent findings that Rho proteins are
needed for membrane fusion, this membrane/organelle-
based actin nucleating activity could be the crucial down-
stream Rho effect as a mechanism to forcibly promote the
fusion of membranes.
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fusion
The isolation of endocytosis (END) mutants in yeast has
established a role for actin and associated proteins in this
process. Many of END mutants are the products of actin
regulators such as the WASp binding partner WIP (End5/
Vrp1), other cytoskeletal elements (End3, -4, -6) and actin
itself (End7/Act1) [52]. Though genetic manipulation in
yeast is a straightforward approach, this is not easily
established in other cell systems.
Another common approach used to study the participa-
tion of actin in cell functions is via its manipulation by
actin-specific drugs and exogenously produced proteins.
Table 1 lists a variety of reagents that have been used andTable 1
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See Ref. [65] for a review of latrunculins and cytochalasins.summarizes their effects on the cytoskeleton and membrane
fusion where applicable.
3.1. F-actin as a barrier/negative regulator of membrane
fusion
3.1.1. Actin-disrupting reagents stimulate membrane fusion
Important evidence for an active role for actin rearrange-
ment comes from early ultrastructural analysis of secretory
granule exocytosis in pancreatic beta cells. In this study,
Orci et al. [7] showed stimulation of insulin secretion by
glucose was significantly increased by mild application of
cytochalasin D (10 Ag/ml) with the concomitant reduction
of microfilament density at the cell cortex. Though this
supports an actin-barrier model, the authors also report that
higher concentration of cytochalasin D (50 Ag/ml) inhibits
exocytosis. They conclude that actin plays a dual role, both
restrictive and perhaps also needed to give the final impulse
for exocytosis. Twenty-three years later Muallem et al. [12]
repeated very similar experiments using the more selective
actin-depolymerizing reagents h-thymosin and gelsolin.
Essentially they obtained the same result; mild application
of these reagents on permeabilized pancreatic acinar cells
stimulates exocytosis, while higher concentrations inhibit
exocytosis. Once inhibited, exocytosis could not be restored
by other downstream stimulating agonists, suggesting that
membrane fusion requires a minimal actin cytoskeleton or
its transient reassembly. Similar biphasic results were
shown for receptor-mediated endocytosis; low or high
concentrations of h-thymosin promoted or inhibited endo-
cytosis, respectively, whereas latrunculin only inhibited
(cytochalasins had no effect) [53]. The effect of actin-
depolymerizing drugs was also recently examined in pri-
mary hippocampal neuron exocytosis. Application of
latrunculin A (but not cytochalasins) rapidly increased the
rate of neurotransmitter release though these authors did not
find (or search for) inhibitory concentrations [54]. Interest-
ingly, in both of these studies exocytosis was stimulated in
the absence of normal activators (i.e. glucose for pancreatic
acinar cells and calcium for neurons), which suggests that
actin remodeling may indeed be a sufficient final trigger for
exocytosis.
This latter study describes the role of actin-dependent
regulated exocytosis as a restraining mechanism, which
agrees well with several former studies that examined the
effect of PKC activation (via PMA) and the stimulation of
exocytosis in chromoffin cells [10,55–57]. In these experi-
ments, cortical actin reduction precedes exocytosis and both
actin reduction and exocytosis could be significantly en-
hanced by PKC activation. Activation also caused the actin
severing protein, scinderin, to be recruited to active zones of
exocytosis. Taken together, these experiments provided the
basis of an actin-barrier model, and its transiently disassem-
bly is required to produce an active zones of exocytosis
where vesicles can freely translocate and fuse with the
plasma membrane.
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3.2.1. Actin-disrupting reagents inhibit membrane fusion
Though the studies previously discussed, in general, do
not provide any evidence for positive role for actin poly-
merization, they also do not preclude such an additional role
since high levels of drug were often found to inhibit endo-
and exocytosis [7,12,53]. The fact that intact or permeabi-
lized cell systems were used in these studies may have
hindered the direct examination of fusion events in the
absence of other cytoskeletal effects. Furthermore, a detailed
microscopic examination of vesicle movement in whole
cells showed that actin depolymerization with the potent
microfilament-disrupting drug, latrunculin B, reduced the
movement of cortical secretory vesicles, contrary to the
actin-barrier model, which predicts that disruption of actin
would remove a restraint on vesicle movement [1]. They
also found that F-actin stabilization with phalloidin blocked
vesicle movement and thus concluded that active actin
remodeling is needed for exocytosis in their neuronal
PC12 cells. Latrunculin B also inhibits secretion in ago-
nist-induced rat peritoneal mast cells [58]. Both intact and
permeabilized cells were examined with somewhat variable
results. Whereas latrunculin B-treated intact cells could not
be stimulated to exocytose in response to agonists, similarly
treated permeabilized cells could still exocytose when
stimulated by GTPgS, but not when stimulated with calci-
um. These results suggest that two unique mechanisms may
control secretion, one controlled by calcium and actin and a
second pathway activated by GTPgS.
Two in vitro membrane fusion systems have recently
reported affects due to actin ligand addition. Heterotypic
fusion between latex bead phagosomes and endocytic
organelles has recently been established and shown to be
sensitive to both latrunculin A and cytochalasin D in vivo,
and also to cytochalasin D and phalloidin-stabilized F-actin
in vitro [13]. Purified phagosomes synthesize F-actin de
novo when reconstituted with pure actin or cytosolic
extracts, which links the inhibition via actin-disrupting
reagents to an authentic process. Contrary to these results,
the actin-disrupting agent, gelsolin, stimulated fusion simi-
lar to that reported for the stimulation of exocytosis in
permeabilized acinar cells [12]. However, direct examina-
tion of F-actin nucleation on isolated phagosomes also
revealed a stimulation of this process in the presence of
gelsolin [59].
Yeast homotypic vacuole fusion also clearly shows a
role for actin remodeling in the membrane fusion process
[14]. Both latrunculin B and jasplakinolide inhibit vacuole
membrane fusion but, interestingly, different subreactions
showed distinct sensitivities. The process of homotypic
vacuole fusion has been divided into three separate sub-
reactions of priming, docking and membrane fusion. Events
that occur within each of these subreactions can be thor-
oughly examined through the use of reversible inhibitors of
each subreaction [22] (for review see Ref. [60]). Latruncu-lin B inhibits the final membrane fusion subreaction as
determined by specifically staged subreactions and kinetic
assays. However, jasplakinolide only inhibits the docking
subreaction. When presented with ‘‘post-docking/pre-fu-
sion’’ vacuoles, membrane fusion was no longer sensitive
to jasplakinolide though it remained sensitive to latrunculin
B. These results in combination with former observations
provide evidence for the following interpretation: actin
depolymerization is initially required to allow membranes
to dock (as judged by the inhibition of the docking sub-
reaction by F-actin stabilization via jasplakinolide), whereas
the final membrane fusion process requires the reestablish-
ment of an actin network (as judged by the inhibition of the
final fusion subreaction by F-actin destabilization via
latrunculin B).4. Conclusion
It is conceivable that actin plays different roles at distinct
steps of the vesicular trafficking pathways. These roles may
be highlighted differentially using different experimental
conditions as examined within this review. Perhaps this
explains, in part, the heterogeneous results of similar studies
by different labs. The final conclusion is that actin remodel-
ing does participate in membrane fusion. Confirmation of
whether F-actin removal or its resynthesis (or both) is
required will await further studies. Importantly, actin remod-
eling machinery is ubiquitously present throughout the cell.
Therefore, once the regulatory mechanisms of actin’s role
are better understood, this process is likely to be universally
applicable to all membrane fusion events.
The recent finding in several laboratories that Rho
proteins are needed for membrane fusion provides a signif-
icant link to the regulation of this process via actin remod-
eling. Rho proteins act as spatial landmarks in general, and
this is particularly apparent from studies of polarized secre-
tion. Does membrane fusion need a spatial landmark? A
recent report by Wang et al. [61] spatially defined fusion site
to the vertices of docked membranes. Proteins known to
participate in the fusion process (i.e. SNAREs, Rabs, Rab
effectors) are significantly enriched in these membrane
micro-domains. Rho may act to landmark the vertices for
an actin remodeling event, which may initially be actin
removal from the boundary membrane and secondly be the
reestablishment of actin filaments across docked vesicle.
This is an amenable hypothesis as such mechanisms could
provide physical restrictions, membrane perturbations and
the force to finally fuse two membranes into one.References
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